Group 1 - The core point of the article is that Suzhou Bili Medical Technology Co., Ltd. has recently completed a Series C financing round, raising several tens of millions of RMB, with investment from PwC Capital and Deep Rock Venture Capital [1] - Suzhou Bili Medical Technology Co., Ltd. was established in 2017 and is located in Suzhou, focusing on research and experimental development [1] - The company has a registered capital of 12.15478997 million RMB and has completed its Series C financing by 2025, with the transaction amount being several tens of millions of RMB [1] Group 2 - The company has made investments in 5 other enterprises and holds 42 trademark registrations and 94 patents, along with 88 administrative licenses [1] - The shareholders of Suzhou Bili Medical Technology Co., Ltd. include Li Jummin, Sinovation Fund IV, L.P., Suzhou Bishi Enterprise Management Partnership (Limited Partnership), Xiamen Deyi Changsheng Venture Capital Partnership (Limited Partnership), and Suzhou Biyuan Enterprise Management Partnership (Limited Partnership) [1]
苏州碧利医疗科技有限公司获“C轮”融资，金额数千万人民币
Sou Hu Cai Jing·2025-12-23 02:16